Mirati Therapeutics, Inc.·4

Aug 16, 4:15 PM ET

CARTER BRUCE L A 4

4 · Mirati Therapeutics, Inc. · Filed Aug 16, 2022

Insider Transaction Report

Form 4
Period: 2022-08-12
Transactions
  • Sale

    Common Stock

    2022-08-12$85.96/sh4,893$420,6126,021 total
  • Exercise/Conversion

    Common Stock

    2022-08-12$27.00/sh+10,000$270,00016,021 total
  • Sale

    Common Stock

    2022-08-12$85.04/sh5,107$434,28710,914 total
  • Exercise/Conversion

    Non Qualified Stock Option (right to buy)

    2022-08-1210,0000 total
    Exercise: $27.00Exp: 2028-01-17Common Stock (10,000 underlying)
Footnotes (3)
  • [F1]This transaction was executed in multiple trades at prices ranging from $84.55 to $85.47. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F2]This transaction was executed in multiple trades at prices ranging from $85.60 to $86.555. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F3]The shares subject to the Option vested and became exercisable in 12 equal monthly installments following the date of grant.

Documents

1 file
  • 4
    marketforms-56893.xmlPrimary

    PRIMARY DOCUMENT